Terry Clayton is a chemist who has authored or co-authored numerous patents and publications related to GABAergic agents and their use in treating memory deficits. He has synthesized novel ligands for GABAA receptors containing the 留5 subunit. Clayton has also given many presentations on his research at national conferences. His research focuses on developing subtype selective ligands to treat memory impairments.